Announcements Trials
Browse Landscape

Phase

Phase 2 309Phase 1 184Phase 3 65Phase 1/2 53Phase 2/3 10Phase 4 6Phase EARLY_PHASE1 5Phase NA 2

Status

Unknown 5Withdrawn 4Terminated 3Recruiting 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Irinotecan × Clear all
NCT02256800 2021-11-17

Escalated Dose of Irinotecan in mCRC

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase NA Completed
213 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01366118 2011-06-03

TT

Grupo Hospital de Madrid

Phase NA Completed
16 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡